PENC Trademark

Trademark Overview


On Thursday, June 7, 2018, a trademark application was filed for PENC with the United States Patent and Trademark Office. The USPTO has given the PENC trademark a serial number of 79238225. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by Oncopeptides AB. The PENC trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, medicinal and veterinary preparations and substances for the treatment of cancer, neoplastic diseases and multiple myeloma; chemical preparations for medical use for the treatment of cancer, neoplastic diseases and multiple myeloma; drug delivery agents in the form of conjugates that facilitate the delivery of pharmaceutical preparations

Chemical preparations and substances for use as pharmaceutical intermediates; chemical products for use in pharmaceuticals

Pharmaceutical research services; biomedical research services; chemical research services; development of pharmaceutical preparations and medicines; laboratory research and analysis services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; laboratory testing services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; medical laboratory services
penc

General Information


Serial Number79238225
Word MarkPENC
Filing DateThursday, June 7, 2018
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5815845
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesPharmaceutical, medicinal and veterinary preparations and substances for the treatment of cancer, neoplastic diseases and multiple myeloma; chemical preparations for medical use for the treatment of cancer, neoplastic diseases and multiple myeloma; drug delivery agents in the form of conjugates that facilitate the delivery of pharmaceutical preparations
Goods and ServicesChemical preparations and substances for use as pharmaceutical intermediates; chemical products for use in pharmaceuticals
Goods and ServicesPharmaceutical research services; biomedical research services; chemical research services; development of pharmaceutical preparations and medicines; laboratory research and analysis services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; laboratory testing services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; medical laboratory services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, August 13, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 13, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOncopeptides AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSE

Party NameOncopeptides AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE

Party NameOncopeptides AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events


Event DateEvent Description
Monday, September 24, 2018ASSIGNED TO EXAMINER
Thursday, August 9, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 17, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, September 25, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 26, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 26, 2018REFUSAL PROCESSED BY MPU
Wednesday, September 26, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 13, 2018REFUSAL PROCESSED BY IB
Tuesday, March 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2019ASSIGNED TO LIE
Wednesday, April 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 1, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 1, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, May 18, 2019NOTIFICATION PROCESSED BY IB
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 18, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 6, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 18, 2019FINAL DISPOSITION PROCESSED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED